Formula makers shift away from BPA
This article was originally published in The Tan Sheet
Executive Summary
Manufacturers of liquid infant formula are seeking alternatives to bisphenol A to use in can linings, with FDA's blessing. CFSAN Director Stephen Sundlof says at the Science Board meeting Feb. 22, "They've come to the decision that rather than spending their time trying to reformulate a BPA-based epoxy, that they really need ... new alternatives. And having seen the research, we tend to agree with them." The agency in January said it has some concern about BPA's effects on fetuses, infants and children (1"The Tan Sheet" Jan. 25, 2010). CFSAN soon will post the results of its BPA studies for public comment
You may also be interested in...
FDA Shift On BPA May Tighten Squeeze On Infant Formula Manufacturers
FDA's shift in position regarding the safety of bisphenol A likely will expedite the trend toward BPA-free packaging among infant formula marketers, even though existing science does not demonstrate a proven threat to babies and children
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.